• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性复发性多灶性骨髓炎患者抗TNF治疗后发生坏疽性脓皮病:药物反应还是疾病的皮肤表现?结合典型病例报告对该主题的批判性综述

Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.

作者信息

Romagnuolo Maurizio, Moltrasio Chiara, Iannone Claudia, Gattinara Maurizio, Cambiaghi Stefano, Marzano Angelo Valerio

机构信息

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

出版信息

Front Med (Lausanne). 2023 May 31;10:1197273. doi: 10.3389/fmed.2023.1197273. eCollection 2023.

DOI:10.3389/fmed.2023.1197273
PMID:37324147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10264797/
Abstract

Chronic recurrent multifocal osteomyelitis (CRMO) is a rare autoinflammatory disease, clinically characterized by chronic and recurrent episodes of osteoarticular inflammation, that generally presents in children and adolescents. From a dermatological point-of-view, CMRO can be associated with skin rashes mainly including psoriasis, palmoplantar pustulosis and acne. Pyoderma gangrenosum (PG) is a rare immune-mediated inflammatory skin disease classified within the spectrum of neutrophilic dermatoses that, in some cases, has been reported as cutaneous manifestation in CMRO patients. This paper presents a 16-year female patient diagnosed with CMRO, who presented PG lesions located on the lower leg, that arose after the administration of the tumour necrosis factor (TNF)-α inhibitor adalimumab. Cases of PG have been reported in patients being treated with certain medications, including TNF-α antagonists, leading to classified them in a setting aptly termed "drug-induced PG." In this paper, we discuss the co-occurrence of PG and CRMO, in the light of recent evidence on the pathogenesis of both diseases and giving ample space to a literature review on drug induced PG. In our case, it is plausible that PG could be considered a cutaneous manifestation of CRMO, although the mechanisms underlying this intriguingly relationship remain to be fully unraveled.

摘要

慢性复发性多灶性骨髓炎(CRMO)是一种罕见的自身炎症性疾病,临床特征为骨关节炎症的慢性反复发作,多见于儿童和青少年。从皮肤病学角度来看,CRMO可伴有皮疹,主要包括银屑病、掌跖脓疱病和痤疮。坏疽性脓皮病(PG)是一种罕见的免疫介导性炎症性皮肤病,属于嗜中性皮肤病范畴,在某些情况下,已被报道为CRMO患者的皮肤表现。本文介绍了一名16岁诊断为CRMO的女性患者,其小腿出现PG皮损,该皮损在使用肿瘤坏死因子(TNF)-α抑制剂阿达木单抗后出现。已有PG病例在接受某些药物治疗的患者中被报道,包括TNF-α拮抗剂,这导致将其归类于“药物性PG”这一恰当命名的情况。在本文中,我们根据这两种疾病发病机制的最新证据,对PG和CRMO的共现情况进行了讨论,并对药物性PG的文献综述给予了充分篇幅。在我们的病例中,PG可被认为是CRMO的一种皮肤表现,尽管这种有趣关系背后的机制仍有待充分阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/10264797/b9aa75650fff/fmed-10-1197273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/10264797/f6201fb05d28/fmed-10-1197273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/10264797/b9aa75650fff/fmed-10-1197273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/10264797/f6201fb05d28/fmed-10-1197273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb24/10264797/b9aa75650fff/fmed-10-1197273-g002.jpg

相似文献

1
Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.慢性复发性多灶性骨髓炎患者抗TNF治疗后发生坏疽性脓皮病:药物反应还是疾病的皮肤表现?结合典型病例报告对该主题的批判性综述
Front Med (Lausanne). 2023 May 31;10:1197273. doi: 10.3389/fmed.2023.1197273. eCollection 2023.
2
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
3
Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.坏疽性脓皮病与掌跖脓疱病的罕见关联:一例报告及既往文献综述
J Dermatol. 2014 Aug;41(8):732-5. doi: 10.1111/1346-8138.12543. Epub 2014 Jul 2.
4
Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab.阿达木单抗成功治疗一名患有坏疽性脓皮病、斑块状银屑病和掌跖脓疱病的患者。
Clin Cosmet Investig Dermatol. 2022 Sep 20;15:1991-1995. doi: 10.2147/CCID.S373115. eCollection 2022.
5
Neutrophilic dermatoses: a review of current treatment options.嗜中性皮肤病:当前治疗选择综述
Am J Clin Dermatol. 2009;10(5):301-12. doi: 10.2165/11310730-000000000-00000.
6
Cranial aseptic osteomyelitis associated with pyoderma gangrenosum.与坏疽性脓皮病相关的无菌性颅骨骨髓炎。
Neurocirugia (Astur : Engl Ed). 2022 Jan-Feb;33(1):46-50. doi: 10.1016/j.neucie.2020.11.003. Epub 2021 Dec 23.
7
Canakinumab treatment in a young girl with refractory chronic recurrent multifocal osteomyelitis associated with pyoderma gangrenosum.卡那单抗治疗伴有坏疽性脓皮病的难治性慢性复发性多灶性骨髓炎的年轻女孩。
Int J Rheum Dis. 2022 Nov;25(11):1333-1338. doi: 10.1111/1756-185X.14425. Epub 2022 Aug 24.
8
Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.坏疽性脓皮病、痤疮和化脓性汗腺炎综合征:一例报告及文献综述
Front Med (Lausanne). 2022 Mar 24;9:856786. doi: 10.3389/fmed.2022.856786. eCollection 2022.
9
Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of bone involvement.两种表型的慢性复发性多灶性骨髓炎,具有不同的骨骼受累模式。
Pediatr Rheumatol Online J. 2022 Dec 1;20(1):108. doi: 10.1186/s12969-022-00772-w.
10
A Comprehensive Review of Neutrophilic Diseases.中性粒细胞疾病的全面综述。
Clin Rev Allergy Immunol. 2018 Feb;54(1):114-130. doi: 10.1007/s12016-017-8621-8.

引用本文的文献

1
Case Report: Effectiveness of deucravacitinib in chronic recurrent multifocal osteomyelitis and concomitant psoriasis.病例报告:德卡伐替尼治疗慢性复发性多灶性骨髓炎及伴发银屑病的疗效
Front Immunol. 2025 May 22;16:1480810. doi: 10.3389/fimmu.2025.1480810. eCollection 2025.
2
Pyoderma gangrenosum in a patient with multiple sclerosis under natalizumab treatment: a case report.接受那他珠单抗治疗的多发性硬化症患者发生坏疽性脓皮病:一例报告
BMC Neurol. 2025 Apr 2;25(1):137. doi: 10.1186/s12883-025-04146-z.
3
Gasdermin D-dependent neutrophil extracellular traps exacerbate cytokine storm contributing to pyoderma gangrenosum pathogenesis.

本文引用的文献

1
Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease.不同的分子通路在坏疽性脓皮病患者中被破坏,并与疾病的严重程度相关。
Sci Rep. 2023 Mar 25;13(1):4919. doi: 10.1038/s41598-023-31914-z.
2
Practical aspects of the diagnosis and management of pyoderma gangrenosum.坏疽性脓皮病诊断与管理的实践要点
Front Med (Lausanne). 2023 Feb 14;10:1134939. doi: 10.3389/fmed.2023.1134939. eCollection 2023.
3
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway.
gasdermin D依赖性中性粒细胞胞外陷阱加剧细胞因子风暴,促进坏疽性脓皮病的发病机制。
iScience. 2025 Jan 30;28(3):111925. doi: 10.1016/j.isci.2025.111925. eCollection 2025 Mar 21.
4
Update on the diagnosis and treatment of CNO in children: a clinician's perspective.儿童先天性外侧裂脑膨出的诊治进展:临床医生视角。
Eur J Pediatr. 2024 Nov 27;184(1):48. doi: 10.1007/s00431-024-05823-w.
5
Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors.肿瘤坏死因子抑制剂治疗患者的矛盾性银屑病:潜在发病机制和遗传因素的作用。
Int J Mol Sci. 2024 Jun 27;25(13):7018. doi: 10.3390/ijms25137018.
6
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review.脓疱性坏疽性皮肤病中的人类先天性免疫缺陷:系统评价。
Am J Clin Dermatol. 2024 Sep;25(5):701-716. doi: 10.1007/s40257-024-00875-y. Epub 2024 Jul 1.
7
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.从药物相关性大疱性表皮松解症的分子见解到临床观点。
Int J Mol Sci. 2023 Nov 26;24(23):16786. doi: 10.3390/ijms242316786.
慢性炎症通过激活可用药的 Jak/Stat3 信号通路降低造血干细胞的功能。
EMBO Rep. 2023 Jan 9;24(1):e54729. doi: 10.15252/embr.202254729. Epub 2022 Nov 7.
4
Blood transcriptomics to facilitate diagnosis and stratification in pediatric rheumatic diseases - a proof of concept study.血液转录组学辅助儿科风湿性疾病的诊断和分层 - 概念验证研究。
Pediatr Rheumatol Online J. 2022 Oct 17;20(1):91. doi: 10.1186/s12969-022-00747-x.
5
Canakinumab treatment in a young girl with refractory chronic recurrent multifocal osteomyelitis associated with pyoderma gangrenosum.卡那单抗治疗伴有坏疽性脓皮病的难治性慢性复发性多灶性骨髓炎的年轻女孩。
Int J Rheum Dis. 2022 Nov;25(11):1333-1338. doi: 10.1111/1756-185X.14425. Epub 2022 Aug 24.
6
Paradoxical reactions and biologic agents: a French cohort study of 9303 patients.矛盾反应和生物制剂:一项对 9303 名患者的法国队列研究。
Br J Dermatol. 2022 Nov;187(5):676-683. doi: 10.1111/bjd.21716. Epub 2022 Jul 12.
7
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.生物治疗期间的反常性化脓性汗腺炎:一项新出现的挑战——系统评价
Biomedicines. 2022 Feb 16;10(2):455. doi: 10.3390/biomedicines10020455.
8
Analysis of the fecal and oral microbiota in chronic recurrent multifocal osteomyelitis.慢性复发性多灶性骨髓炎的粪便和口腔微生物组分析。
Arthritis Res Ther. 2022 Feb 22;24(1):54. doi: 10.1186/s13075-021-02711-8.
9
Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO).慢性非细菌性骨髓炎(CNO)和慢性复发性多灶性骨髓炎(CRMO)。
J Transl Autoimmun. 2021 Mar 20;4:100095. doi: 10.1016/j.jtauto.2021.100095. eCollection 2021.
10
Pyoderma gangrenosum induced by adalimumab in a seropositive rheumatoid arthritis patient: a paradoxical effect of adalimumab?阿达木单抗诱导血清阳性类风湿关节炎患者发生坏疽性脓皮病:阿达木单抗的矛盾效应?
Rheumatology (Oxford). 2021 Aug 2;60(8):e288-e289. doi: 10.1093/rheumatology/keab194.